February News Roundup: What's New in Research?

World’s Smallest Pacemaker Revealed – Read More >

The Micra Transcatheter Pacing System (TPS), a new pacemaker the size of a nickel, can now be implanted in patients with bradycardia to help pump enough blood through the body during physical activity. The tiny device is just 1/10th the size of a traditional pacemaker, and it is currently the only leadless pacemaker approved for use in the United States. The TPS is also unique in that it doesn’t require cardiac wires or a surgical pocket under the skin to deliver a pacing therapy.

NIH Initiates Pilot Grant Program for Innovative Neurological Research – Read More >

The National Institute of Neurological Disorders and Stroke (NINDS), a part of the NIH, has announced the first 30 recipients of the new R35 Research Program Award. This pilot program is designed to foster research by providing more stable funding. Recipients of this award receive five years of research funding, with the potential to extend their funding for three more years. The funding allows investigators to pursue more innovative research projects and spend less time on grants.

How Samsung is Leveraging VR to Manage Pain – Read More >

In an effort to find alternatives to opioid prescriptions for pain management, a new startup called AppliedVR has developed a virtual reality platform with games and relaxing landscapes to draw users away from their pain. The platform is based in Samsung’s virtual reality hardware Gear VR. Samsung and AppliedVR are currently working together with a group of hospitals to examine the technology for both children and adults. Positive results have already come back from Cedars-Sinai Medical Center.

FDA Unveils Clinical Trial Diversity Tools – Read More >

The U.S. Food and Drug Administration has released several resources as part of an ongoing effort to promote clinical trial diversity. A social media toolkit, clinical trial factsheets, and consumer updates are just a few of the various tools set out by the FDA. Historically, a few groups of individuals such as women, the elderly, and racial/ethnic minorities have been underrepresented in research, which the FDA hopes to change with this initiative.

Looking for more research news? Check out these resources:

CenterWatch News Online

World Pharma News

Applied Clinical Trials